This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Cebina Gmbh, Eveliqure Biotechnologies Gmbh. Active years: 2017-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2026
Title: Tamás Henics: Innovator in Vaccine Development
Introduction
Tamás Henics is a prominent inventor based in Vienna, Austria. He has made significant contributions to the field of immunology, particularly in vaccine development. His innovative work focuses on creating effective solutions to combat infectious diseases.
Latest Patents
Henics holds a patent for a live attenuated Shigella vaccine. This vaccine is based on a rough strain that lacks LPS O-antigen and is designed to be non-invasive through a mutation of the invasion plasmid. It aims to provide immunoprophylaxis to prevent enteral diseases. The vaccine includes a strain with a deletion of the rfb F, ipa B, and/or ipa C genes, along with a recombinant plasmid vector that encodes at least one heterologous antigen.
Career Highlights
Tamás Henics is associated with Eveliqure Biotechnologies GmbH, where he continues to advance his research and development efforts. His work is crucial in the ongoing fight against infectious diseases, showcasing his dedication to public health.
Collaborations
Henics collaborates with notable colleagues, including Gábor Nagy and Valeria Szijárto. Their combined expertise enhances the research and development processes at Eveliqure Biotechnologies GmbH.
Conclusion
Tamás Henics is a key figure in the field of vaccine innovation, with a focus on developing effective solutions for infectious diseases. His contributions are vital for advancing public health and improving immunization strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile